A detailed history of Rathbones Group PLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Rathbones Group PLC holds 2,405,458 shares of BSX stock, worth $218 Million. This represents 1.06% of its overall portfolio holdings.

Number of Shares
2,405,458
Previous 2,407,186 0.07%
Holding current value
$218 Million
Previous $185 Million 8.74%
% of portfolio
1.06%
Previous 1.04%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$72.96 - $84.0 $126,074 - $145,152
-1,728 Reduced 0.07%
2,405,458 $202 Million
Q2 2024

Aug 09, 2024

BUY
$67.33 - $77.71 $3.62 Million - $4.18 Million
53,770 Added 2.28%
2,407,186 $185 Million
Q1 2024

May 14, 2024

BUY
$57.6 - $68.62 $457,804 - $545,391
7,948 Added 0.34%
2,353,416 $161 Million
Q4 2023

Feb 13, 2024

BUY
$48.64 - $57.81 $4.02 Million - $4.78 Million
82,646 Added 3.65%
2,345,468 $136 Million
Q3 2023

Nov 13, 2023

BUY
$50.19 - $54.68 $13.1 Million - $14.3 Million
260,964 Added 13.04%
2,262,822 $119 Million
Q2 2023

Aug 04, 2023

BUY
$49.72 - $54.64 $27.7 Million - $30.4 Million
556,884 Added 38.54%
2,001,858 $108 Million
Q1 2023

May 12, 2023

SELL
$45.09 - $50.03 $136,261 - $151,190
-3,022 Reduced 0.21%
1,444,974 $72.3 Million
Q4 2022

Feb 14, 2023

SELL
$39.56 - $47.22 $109,937 - $131,224
-2,779 Reduced 0.19%
1,447,996 $67 Million
Q3 2022

Nov 03, 2022

BUY
$36.71 - $109.66 $53.3 Million - $159 Million
1,450,775 New
1,450,775 $56.2 Million
Q4 2021

Feb 10, 2022

SELL
$38.07 - $44.87 $237,747 - $280,213
-6,245 Closed
0 $0
Q3 2021

Nov 04, 2021

BUY
$41.23 - $45.88 $257,481 - $286,520
6,245 New
6,245 $271,000
Q1 2021

May 14, 2021

SELL
$35.27 - $39.67 $837,486 - $941,964
-23,745 Closed
0 $0
Q4 2020

Feb 11, 2021

SELL
$33.15 - $41.97 $5.63 Million - $7.13 Million
-169,940 Reduced 87.74%
23,745 $854,000
Q3 2020

Nov 13, 2020

SELL
$34.44 - $42.23 $172,200 - $211,149
-5,000 Reduced 2.52%
193,685 $7.4 Million
Q2 2020

Aug 07, 2020

BUY
$30.19 - $39.11 $760,938 - $985,767
25,205 Added 14.53%
198,685 $6.98 Million
Q1 2020

May 04, 2020

SELL
$25.83 - $45.71 $19.4 Million - $34.3 Million
-750,520 Reduced 81.23%
173,480 $5.66 Million
Q4 2019

Feb 11, 2020

BUY
$37.87 - $45.37 $4.16 Million - $4.99 Million
109,979 Added 13.51%
924,000 $41.8 Million
Q3 2019

Nov 13, 2019

BUY
$40.31 - $43.45 $913,021 - $984,142
22,650 Added 2.86%
814,021 $33.1 Million
Q2 2019

Aug 12, 2019

BUY
$34.91 - $42.98 $23 Million - $28.3 Million
658,328 Added 494.82%
791,371 $34 Million
Q1 2019

May 09, 2019

BUY
$32.91 - $40.75 $103,699 - $128,403
3,151 Added 2.43%
133,043 $5.11 Million
Q4 2018

Feb 12, 2019

BUY
$31.73 - $39.04 $1.64 Million - $2.02 Million
51,821 Added 66.38%
129,892 $4.59 Million
Q3 2018

Oct 12, 2018

BUY
$32.83 - $38.63 $2.56 Million - $3.02 Million
78,071 New
78,071 $3.01 Million

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $130B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Rathbones Group PLC Portfolio

Follow Rathbones Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rathbones Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Rathbones Group PLC with notifications on news.